Corbin Therapeutics Inc

📍 Westmount, Canada🗓 Founded 2016👥 2 employees💰 Last funded Sep 2018
Biotechnology Research
LinkedIn
Corbin Therapeutics is a spin-off company from AmorChem Fund 1, developing a sophisticated in-vivo genome-wide screening platform in mice undergoing experimental neuro-inflammation, from the laboratory of Dr Philippe Gros, Faculty of Medicine, McGill University, leading to a novel anti-inflammatory target in the deubiquitinylation (DUB) family of enzymes, more particularly USP15.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
3
Investor activity2017–2018 · investors recorded per year
2017220181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Corbin Therapeutics Inc?
Corbin Therapeutics Inc has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Corbin Therapeutics Inc last raise funding?
The most recent investment in Corbin Therapeutics Inc recorded on gritt.io was in September 2018.
When was Corbin Therapeutics Inc founded?
Corbin Therapeutics Inc was founded in 2016.
What industry is Corbin Therapeutics Inc in?
Corbin Therapeutics Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Corbin Therapeutics Inc based?
Corbin Therapeutics Inc is headquartered in Westmount, Canada.